Carl Zeiss Meditec Balance Sheet Health
Financial Health criteria checks 5/6
Carl Zeiss Meditec has a total shareholder equity of €2.2B and total debt of €155.7M, which brings its debt-to-equity ratio to 7.2%. Its total assets and total liabilities are €3.0B and €860.0M respectively. Carl Zeiss Meditec's EBIT is €335.8M making its interest coverage ratio -18.8. It has cash and short-term investments of €10.6M.
Key information
7.2%
Debt to equity ratio
€155.70m
Debt
Interest coverage ratio | -18.8x |
Cash | €10.60m |
Equity | €2.17b |
Total liabilities | €860.02m |
Total assets | €3.03b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AFX's short term assets (€1.9B) exceed its short term liabilities (€561.6M).
Long Term Liabilities: AFX's short term assets (€1.9B) exceed its long term liabilities (€298.4M).
Debt to Equity History and Analysis
Debt Level: AFX's net debt to equity ratio (6.7%) is considered satisfactory.
Reducing Debt: AFX's debt to equity ratio has increased from 0.8% to 7.2% over the past 5 years.
Debt Coverage: AFX's debt is well covered by operating cash flow (161.1%).
Interest Coverage: AFX earns more interest than it pays, so coverage of interest payments is not a concern.